UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$511M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$419M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$353M |
| 4 |
SPDR Gold Trust
GLD
|
+$285M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.21B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$1.14B |
| 3 |
Microsoft
MSFT
|
+$1.08B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$790M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.27% |
| 2 | Technology | 10.83% |
| 3 | Healthcare | 6.32% |
| 4 | Consumer Discretionary | 6.26% |
| 5 | Financials | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
McGrath RentCorp
MGRC
$2.77B
| $1.45M | ﹤0.01% |
26,900
-6,384
| -19% | -$343K |
|
3177
Artesian Resources
ARTNA
$349M
| $1.45M | ﹤0.01% |
39,979
-6,547
| -14% | -$230K |
|
3178
Direxion Daily Technology Bull 3x ETF
TECL
$6.58B
| $1.45M | ﹤0.01% |
+62,280
| New | +$1.1M |
|
|
MYJ
3179
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
| $1.45M | ﹤0.01% |
106,243
-12,362
| -10% | -$164K |
|
3180
CALL
Dominion Energy
D
$53.8B
| $1.45M | ﹤0.01% |
17,800
+16,400
| +1,171% | +$1.32M |
|
|
3181
PUT
Dominion Energy
D
$53.8B
| $1.45M | ﹤0.01% |
+17,800
| New | +$1.43M |
|
|
BSJN
3182
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
| $1.44M | ﹤0.01% |
60,207
-2,440
| -4% | -$57.3K |
|
|
IPHI
3183
DELISTED
INPHI CORPORATION
IPHI
| $1.44M | ﹤0.01% |
12,290
-64,710
| -84% | -$6.81M |
|
|
CIM
3184
PUT
Chimera Investment
CIM
$900M
| $1.44M | ﹤0.01% |
50,000
-116,667
| -70% | -$3M |
|
3185
CALL
B2Gold
BTG
$7.07B
| $1.44M | ﹤0.01% |
+252,500
| New | +$1.27M |
|
|
MEET
3186
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $1.44M | ﹤0.01% |
230,280
+167,582
| +267% | +$1.03M |
|
3187
Carlyle Secured Lending
CGBD
$772M
| $1.44M | ﹤0.01% |
167,484
+165,585
| +8,720% | +$1.29M |
|
3188
Grand Canyon Education
LOPE
$3.93B
| $1.43M | ﹤0.01% |
15,849
-622
| -4% | -$55.3K |
|
3189
CALL
Weibo
WB
$1.61B
| $1.43M | ﹤0.01% |
42,658
+1,858
| +5% | +$63.8K |
|
|
BGX
3190
Blackstone Long-Short Credit Income Fund
BGX
$134M
| $1.43M | ﹤0.01% |
118,741
-32,800
| -22% | -$374K |
|
|
EAD
3191
Allspring Income Opportunities Fund
EAD
$358M
| $1.43M | ﹤0.01% |
203,757
-86,910
| -30% | -$596K |
|
3192
PUT
Papa John's
PZZA
$663M
| $1.43M | ﹤0.01% |
18,000
| – | – |
|
3193
Omnicell
OMCL
$1.5B
| $1.43M | ﹤0.01% |
20,206
-27,971
| -58% | -$1.91M |
|
|
CLVS
3194
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.43M | ﹤0.01% |
211,100
+57,976
| +38% | +$439K |
|
3195
SPS Commerce
SPSC
$2.93B
| $1.42M | ﹤0.01% |
18,954
-9,771
| -34% | -$595K |
|
|
WPX
3196
DELISTED
WPX Energy, Inc.
WPX
| $1.42M | ﹤0.01% |
222,788
-299,158
| -57% | -$1.69M |
|
3197
Opko Health
OPK
$1.27B
| $1.42M | ﹤0.01% |
416,279
-368,149
| -47% | -$825K |
|
3198
Dr. Reddy's Laboratories
RDY
$10.3B
| $1.42M | ﹤0.01% |
133,900
-116,005
| -46% | -$1.18M |
|
|
BGH
3199
Barings Global Short Duration High Yield Fund
BGH
$270M
| $1.42M | ﹤0.01% |
112,759
-1,309
| -1% | -$15.2K |
|
3200
CALL
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.42M | ﹤0.01% |
+29,200
| New | +$1.4M |
|
Similar funds
UBS Group's Q2 2020 Portfolio in Review
As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group withdrew a net $9.52B in Q2 2020, closing 776 positions and reducing 4,000 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.
- UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
- UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
- UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
- UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
- UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
- UBS Group opened 705 new positions and closed 776 in Q2 2020.
- UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.
Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.